World Heart Corp - WHRT and TSE/WHT Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : World Heart Corp - WHRT and TSE/WHT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: reg who wrote (335)	1/5/2000 1:26:00 PM
From: kidl	Read Replies (1) of 500

World Heart changes executive roles World Heart Corp WHT Shares issued 14,078,743 Jan 4 close $14.25 Wed 5 Jan 100 News Release Mr. Roderick Bryden reports World Heart has realigned its executive responsibilities of Dr. Tofy Mussivand and Roderick M. Bryden. Dr. Mussivand has been appointed chairman and chief scientific officer and Mr. Bryden has been appointed president and continues as chief executive officer. The change in roles reflects the evolution of requirements of the corporation. Commencement of HEARTSAVERvad production and clinical trials this year, and the preparations for commercial sale of HEARTSAVERvad next year, will significantly increase the operating demands within the corporation. Coincident with this, the introduction of HEARTSAVERvad to leading clinicians and scientists around the world, and development of next generation technologies and products, requires dedicated attention of the corporation's leading scientist. Mr. Bryden as president and chief executive officer and Dr. Mussivand as chairman and chief scientific officer meet these needs. (c) Copyright 2000 Canjex Publishing Ltd. canada-stockwatch.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next